KOL Perspectives: BTK Inhibitors in RA

Market: Pharmaceuticals and Healthcare

Global, 26 pages report, published by GlobalData

Report ThumbnailAugust-2018
KOL Perspectives: BTK Inhibitors in RA

Summary

This KOL Insight briefing focuses on KOLs views of BTK Inhibitors in RA.

Questions topics -
- Awareness and potential of BTK inhibitors in RA
- Perceptions of BMS-986142’s Phase IItrial design
- Impact of poseltinib discontinuation on existing perception of BTK inhibitors in RA

Key Highlights

- Of the named BTK inhibitors, KOLs demonstrated the greatest awareness of BMS-986142, despite its lack of Phase II data
- KOLs were divided over BMS-986

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: BTK Inhibitors in RAProduct ThumbnailKOL Perspectives: BTK Inhibitors in RA, Industry ReportProduct #: 1194164
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved